Vireo Growth (VREOF) Non-Current Debt (2020 - 2026)

Vireo Growth (VREOF) reported Non-Current Debt of $197.3 million for Q1 2026, up 215.16% on a YoY basis from $62.6 million in Q1 2025, and up 54.62% sequentially from $127.6 million in Q4 2025.

Vireo Growth (VREOF) Non-Current Debt (2020 - 2026) Analysis & Trends

Vireo Growth (VREOF) has 7 years of Non-Current Debt data on file, last reported at $197.3 million in Q1 2026.

  • For the quarter ending Q1 2026, Non-Current Debt rose 215.16% year-over-year to $197.3 million; the trailing twelve-month figure through Mar 2026 stood at $197.3 million (up 215.16% YoY), and the FY2025 full-year result was $127.6 million, up 104.82% from the prior year.
  • Non-Current Debt climbed to $197.3 million in Q1 2026, from $127.6 million in the prior quarter.
  • In the past five years, Non-Current Debt ranged from a high of $197.3 million in Q1 2026 to a low of $1.1 million in Q2 2024.
  • A 5-year average of $63.6 million and a median of $56.0 million in 2023 frame the typical range for Non-Current Debt.
  • Across the five-year window, Non-Current Debt sank 91.82% in 2023 and surged 7232.02% in 2025, its largest moves.
  • Tracing VREOF's Non-Current Debt over 5 years: stood at $46.2 million in 2022, then jumped by 30.21% to $60.2 million in 2023, then gained by 3.45% to $62.3 million in 2024, then jumped by 104.82% to $127.6 million in 2025, then surged by 54.62% to $197.3 million in 2026.
  • Business Quant data shows VREOF's Non-Current Debt at $197.3 million in Q1 2026, $127.6 million in Q4 2025, and $131.7 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 10.34 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 14.02 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 9.05 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 27.86 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 12.41 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 3.74 Bn
10 Vireo Growth 10.57 Bn 10.41 Bn 59.30 Mn 197.30 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 197.30 Mn
Dec 31, 2025 127.60 Mn
Sep 30, 2025 131.67 Mn
Jun 30, 2025 82.21 Mn
Mar 31, 2025 62.60 Mn
Dec 31, 2024 62.30 Mn
Sep 30, 2024 56.83 Mn
Jun 30, 2024 1.12 Mn
Dec 31, 2023 60.22 Mn
Sep 30, 2023 4.06 Mn
Jun 30, 2023 3.90 Mn
Mar 31, 2023 55.16 Mn
Dec 31, 2022 46.25 Mn
Sep 30, 2022 49.61 Mn
Jun 30, 2022 45.85 Mn
Mar 31, 2022 31.21 Mn
Dec 31, 2021 27.33 Mn
Sep 30, 2021 20.52 Mn
Jun 30, 2021 18.53 Mn
Mar 31, 2021 17.65 Mn